Method for preparing levorotatory oxiracetam oral dispersible film preparation

A technology of dispersing film and oral cavity, which is applied in the field of preparing levo-oxiracetam oral dispersible film, can solve the problems of harm to patients, low drug loading, large solid particle agglomeration, etc., and achieve the effect of improving product quality

Inactive Publication Date: 2017-06-13
CHONGQING RUNZE PHARM CO LTD
View PDF8 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This type of preparation is directly injected into tissues or blood vessels, and there is no absorption process or the absorption process is very short, so the blood concentration can quickly reach the peak to play a role; Most require higher equipment conditions, and the drugs in the injection are generally dispersed in water as micron-sized solid particles in the molecular state, with a large degree of dispersion, and high-temperature sterilization often results in drug hydrolysis, oxidation, and solid particle coalescence Stability issues such as large size
At the same time, because the injection directly and quickly enters the human body without the protection of the normal physiological barrier of the human body, if the dosage is improper or the injection is too fast, or there is a problem with the quality of the drug, it may bring harm to the patient, or even cause irreparable consequences.
In addition, injection pain, inability to administer drugs by the patient, local induration of injection, and vascular inflammation caused by intravenous injection are all problems in clinical application.
[0005] CN101732251A discloses a liposome of oxiracetam, which is prepared from oxiracetam, phospholipids, cholesterol, Tween 80 and an appropriate amount of osmotic pressure regulator and buffer solution; the liposome has good stability and encapsulation efficiency High, low toxicity and side effects; but the liposome preparation process is complicated, not suitable for large-scale production; more importantly, the curative effect of liposomes in the human body remains to be further studied, and there are few liposome preparations for clinical use in China at present
Although the oral film has many advantages, the limitations of its film-forming materials and preparation technology lead to low drug loading, the disintegration time and tensile strength are not easy to control, and most of the time it needs to mask the taste, which restricts the oral film. development and application of

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing levorotatory oxiracetam oral dispersible film preparation
  • Method for preparing levorotatory oxiracetam oral dispersible film preparation
  • Method for preparing levorotatory oxiracetam oral dispersible film preparation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0078] The preparation of levoxiracetam orodispersible film, adopts following steps:

[0079] 1) Dissolve 60g of film-forming material (a combination of acrylate and hydroxypropylmethylcellulose, where the dosage of hydroxypropylmethylcellulose is 30g) with 80mL of absolute ethanol, and remove the air bubbles to obtain a uniform viscous liquid;

[0080] 2) Disperse 15g of glycerin, 20g of microcrystalline cellulose, 4g of malic acid and 2g of sorbitol with 50mL of absolute ethanol to form a dispersion;

[0081] 3) Add the dispersion of step 2) to the viscous liquid of step 1), and add 5g of levoxiracetam to disperse evenly, and then let it stand to remove air bubbles;

[0082] 4) Coat the viscous liquid after removing air bubbles with a drug film coating dryer at a coating speed of 50cm / min, then dry at 65-68°C, and peel off.

Embodiment 2

[0084] The preparation of levoxiracetam orodispersible film, adopts following steps:

[0085] 1) Dissolve 40g of film-forming material (a combination of acrylate and hydroxypropylmethylcellulose, wherein the dosage of hydroxypropylmethylcellulose is 10g) with 50mL of absolute ethanol, and remove the air bubbles to obtain a uniform viscous liquid;

[0086] 2) Disperse 20g of propylene glycol, 20g of low-substituted hydroxypropyl cellulose, 2g of citric acid and 1g of xylitol with 60mL of absolute ethanol to form a dispersion;

[0087] 3) Add the dispersion of step 2) to the viscous liquid of step 1), and add 18g of levoxiracetam to disperse evenly, then let it stand to remove air bubbles;

[0088] 4) Coat the viscous liquid after removing air bubbles with a drug film coating dryer at a coating speed of 80cm / min, then dry at 70-72°C, and peel off.

Embodiment 3

[0090] The preparation of levoxiracetam orodispersible film, adopts following steps:

[0091] 1) Dissolve 50g of film-forming material (a combination of acrylate and hydroxypropyl methylcellulose, where the dosage of hydroxypropylmethylcellulose is 20g) with 50mL of absolute ethanol, and remove air bubbles to obtain a uniform viscous liquid;

[0092] 2) Disperse 15g of triethyl citrate, 20g of microcrystalline cellulose, 3g of ascorbic acid and 1g of sorbitol with 40mL of absolute ethanol to form a dispersion;

[0093] 3) Add the dispersion of step 2) to the viscous liquid of step 1), and add 15g of levoxiracetam to disperse evenly, then let it stand to remove air bubbles;

[0094] 4) Coat the viscous liquid after removing air bubbles with a drug film coating dryer at a coating speed of 70cm / min, then dry at 80-85°C, and peel off.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
thicknessaaaaaaaaaa
Login to view more

Abstract

The invention discloses a method for preparing a levorotatory oxiracetam oral dispersible film preparation. The levorotatory oxiracetam oral dispersible film preparation is made by using a film forming material, a plasticizer, a filling agent, a saliva irritant, correctant and levorotatory oxiracetam as raw materials and through coating, drying and stripping by using a film coating and drying machine for a medicinal film. According to the method, the levorotatory oxiracetam oral dispersible film preparation is prepared by using a film coating machine for the medicinal film; the thickness, the coating speed and the drying temperature of the oral dispersible film preparation are strictly controlled; thus, the process is stabilized; the quality of a product is guaranteed; aspects of the brittlement, the disintegration time limit, the dissolution time and the like of the levorotatory oxiracetam oral dispersible film are enabled to be more beneficial to clinical application.

Description

technical field [0001] The invention relates to levo-oxiracetam, in particular to a method for preparing levo-oxiracetam orodispersible film. Background technique [0002] Oxiracetam (Oxiracetam) is a new generation of brain metabolism improving drugs, pyrrolidone (cyclic GABOB) derivatives, piracetam analogs, can promote the synthesis of phosphorylcholine and o-acethanolamine, promote brain metabolism, through the blood brain Barrier has a stimulating effect on specific central nervous pathways, improving intelligence and memory. It has a good curative effect on cerebrovascular disease, brain injury, brain tumor (postoperative), intracranial infection, dementia, and brain degenerative diseases. It is suitable for memory and intellectual impairment caused by mild to moderate vascular dementia, senile dementia and traumatic brain injury. Oxiracetam was synthesized for the first time in 1974 by the Italian Skeleton Bichem Company and launched in 1987. It has better concentra...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/06A61K31/4015A61K47/36A61K47/14A61P25/28
Inventor 叶雷
Owner CHONGQING RUNZE PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products